Stéphane DORICH

Person

Pointe-Claire, CA

People

Patents Grantslast 30 patents

Information Patent Grant
Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors
- Patent number 12,195,460
- Issue date Jan 14, 2025
- Ventus Therapeutics U.S., Inc.
- Stéphane Dorich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives
- Patent number 12,168,657
- Issue date Dec 17, 2024
- Ventus Therapeutics U.S., Inc.
- Stéphane Dorich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of APOL1 and methods of using same
- Patent number 12,116,343
- Issue date Oct 15, 2024
- Vertex Pharmaceuticals Incorporated
- Leslie A. Dakin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives
- Patent number 11,618,751
- Issue date Apr 4, 2023
- Ventus Therapeutics U.S., Inc.
- Stéphane Dorich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for inhibiting NLRP3 and uses thereof
- Patent number 11,319,319
- Issue date May 3, 2022
- Ventus Therapeutics U.S., Inc.
- Stéphane Dorich
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
HETEROCYCLIC COMPOUNDS AND USES THEREOF
- Publication number 20250002487
- Publication date Jan 2, 2025
- Ventus Therapeutics U.S., Inc.
- Ramsay Beveridge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORS
- Publication number 20240409540
- Publication date Dec 12, 2024
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORS
- Publication number 20240383896
- Publication date Nov 21, 2024
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF
- Publication number 20240368160
- Publication date Nov 7, 2024
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OXOINDOLINYL AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF
- Publication number 20240368131
- Publication date Nov 7, 2024
- VENTUS THERAPEUTICS U.S. INC.
- Stéphane Dorich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 DERIVATIVES
- Publication number 20240360127
- Publication date Oct 31, 2024
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORS
- Publication number 20240360130
- Publication date Oct 31, 2024
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF
- Publication number 20240360128
- Publication date Oct 31, 2024
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3
- Publication number 20240360129
- Publication date Oct 31, 2024
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3
- Publication number 20240199606
- Publication date Jun 20, 2024
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORS
- Publication number 20240174661
- Publication date May 30, 2024
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3
- Publication number 20240174668
- Publication date May 30, 2024
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF
- Publication number 20240158396
- Publication date May 16, 2024
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDO[4,3-b]INDOLE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS
- Publication number 20240018138
- Publication date Jan 18, 2024
- Ventus Therapeutics U.S., Inc.
- Lee Fader
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 DERIVATIVES
- Publication number 20230303559
- Publication date Sep 28, 2023
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF
- Publication number 20230159526
- Publication date May 25, 2023
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF
- Publication number 20220340567
- Publication date Oct 27, 2022
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED 2-MORPHOLINOPYRIDINE DERIVATIVES AS ATR KINASE INHIBITORS
- Publication number 20220185809
- Publication date Jun 16, 2022
- Repare Therapeutics Inc.
- Sheldon N. Crane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF PREPARING CO...
- Publication number 20210277002
- Publication date Sep 9, 2021
- Repare Therapeutics Inc.
- Sheldon N. CRANE
- C07 - ORGANIC CHEMISTRY

Stéphane DORICH

Person

Patents Grantslast 30 patents

Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors

Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives

Inhibitors of APOL1 and methods of using same

Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives

Compounds for inhibiting NLRP3 and uses thereof

Patents Applicationslast 30 patents

HETEROCYCLIC COMPOUNDS AND USES THEREOF

PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORS

PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORS

COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF

OXOINDOLINYL AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF

PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 DERIVATIVES

PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORS

COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF

PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3

PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3

PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORS

PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3

COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF

PYRIDO[4,3-b]INDOLE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS

PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 DERIVATIVES

COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF

COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF

SUBSTITUTED 2-MORPHOLINOPYRIDINE DERIVATIVES AS ATR KINASE INHIBITORS

COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF PREPARING CO...